Resultados de procura - Huitema, Alwin D R

Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels por Groenland, Stefanie L., Katz, Daniela, Huitema, Alwin D. R., Steeghs, Neeltje

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter] por Hendrikx, Jeroen J M A, Beijnen, Jos H, Huitema, Alwin D R

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components por Bastida, Carla, Soy, Dolors, Ruiz‐Esquide, Virginia, Sanmartí, Raimon, Huitema, Alwin D.R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis por Dorlo, Thomas P. C., Huitema, Alwin D. R., Beijnen, Jos H., de Vries, Peter J.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice por Simeoli, Raffaele, Dorlo, Thomas P. C., Hanff, Lidwien M., Huitema, Alwin D. R., Dreesen, Erwin

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses por Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152) por Keizer, Ron J., Zandvliet, Anthe S., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia por Boerlage, Thomas C. C., van Hees, Charlotte L. E., Huitema, Alwin D. R., Lauw, Fanny N.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing por Verheijen, Remy B., Beijnen, Jos H., Schellens, Jan H. M., Huitema, Alwin D. R., Steeghs, Neeltje

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes por van Eijk, Maarten, Boosman, René J., Schinkel, Alfred H., Huitema, Alwin D. R., Beijnen, Jos H.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MS por de Jong, Karen A.M., Rosing, Hilde, Vermunt, Marit, Huitema, Alwin D.R., Beijnen, Jos H.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review por Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Correction to: Influence of Malnutrition on the Pharmacokinetics of Drugs Used in the Treatment of Poverty-Related Diseases: A Systematic Review por Verrest, Luka, Wilthagen, Erica A., Beijnen, Jos H., Huitema, Alwin D. R., Dorlo, Thomas P. C.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin por Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′‐difluorodeoxyuridine and their nucleotides por Derissen, Ellen J. B., Huitema, Alwin D. R., Rosing, Hilde, Schellens, Jan H. M., Beijnen, Jos H.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model por ter Heine, Rob, Kane, Sean P., Huitema, Alwin D.R., Krasowski, Matthew D., van Maarseveen, Erik M.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs por Molenaar-Kuijsten, Laura, Van Balen, Dorieke E. M., Beijnen, Jos H., Steeghs, Neeltje, Huitema, Alwin D. R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa por Ekhart, Corine, Doodeman, Valerie D, Rodenhuis, Sjoerd, Smits, Paul H M, Beijnen, Jos H, Huitema, Alwin D R

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents por Zandvliet, Anthe S., Karlsson, Mats O., Schellens, Jan H. M., Copalu, William, Beijnen, Jos H., Huitema, Alwin D. R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer por Koolen, Stijn L W, Oostendorp, Roos L, Beijnen, Jos H, Schellens, Jan H M, Huitema, Alwin D R

Ligazón do recurso Ligazón do recurso Ligazón do recurso